Identifeye Health has developed a portable retinal imaging system that captures high-quality images to detect early signs of diabetic retinopathy and other health conditions during routine primary care visits. This non-invasive approach enhances access to critical screenings, addressing the issue of missed annual retinal exams among diabetic patients.
Funding
$80M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many diabetic patients do not receive annual retinal screenings, leading to delayed detection and treatment of diabetic retinopathy, a leading cause of preventable blindness. Traditional retinal imaging requires specialized equipment and trained personnel, limiting accessibility within primary care settings.
Solution
Identifeye Health offers a portable retinal imaging platform designed for seamless integration into primary care workflows, enabling early detection of diabetic retinopathy and other health conditions. The identifeye Camera is fully automated, capturing high-quality retinal images without the need for specialized training or complex equipment. By bringing retinal screenings into routine check-ups, Identifeye Health enhances access to critical diagnostics, facilitating timely intervention and improved patient outcomes. The platform supports a future suite of AI-powered screening and monitoring tools, addressing significant health challenges through personalized medicine using retinal biomarkers.
Target Audience
The primary target audience includes primary care physicians and healthcare providers seeking to improve early detection of diabetic retinopathy in diabetic patients.
Features
- Portable and fully automated retinal imaging system
- Streamlined workflow for easy integration into primary care settings
- High-quality retinal images captured without specialized training
- AI-powered screening and monitoring tools for future diagnostics
- Personalized medicine using retinal biomarkers